CatalystMacro

Eli Lilly-backed TRex Bio targets up to $133M in U.S. IPO

Eli Lilly-backed TRex Bio targets up to $133M in U.S. IPO.

What changed

Eli Lilly-backed TRex Bio targets up to $133M in U.S. IPO.

Why it matters

Eli Lilly-backed TRex Bio targets up to $133M in U.S. IPO. — impact context not separately stored; see What changed.

Sources